Site Map
Site Map of
http://www.researchandmarkets.com
-
Site Map
-
Pharmaceuticals and Healthcare
-
Pharmaceuticals 1
(
Latest Titles
)
Pharmaceuticals 2
Pharmaceuticals 3
Pharmaceuticals 4
-
Cardiovascular
<< You are in This Category
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
2000 Cardiovascular Market Review: Bringing the Cardiovascular Market Together
static version
printer friendly
pdf version
2007 Essentials of the US Hospital IT Market - Cardiology PACS Chapter
static version
printer friendly
pdf version
^ Top
A
A Nurses Guide to Caring for Cardiac Intervention Patients
static version
printer friendly
pdf version
Abdominal Aortic Aneurysm Treatment: A Panel Discussion among Eight Vascular Surgeons
static version
printer friendly
pdf version
Advances in Coronary Angioplasty: Drug Eluting Stents
static version
printer friendly
pdf version
AIIRBS: Benefits Beyond Blood Pressure: Seeking Indications Throughout The Cardiovascular Continuum
static version
printer friendly
pdf version
Angiogenesis Modulators
static version
printer friendly
pdf version
Anti-hypertensives: Patent Defense Strategies - Combating Generic Competition Through Lifecycle Management
static version
printer friendly
pdf version
Antidyslipidemics - The Power Of Two
static version
printer friendly
pdf version
Antithrombotics in Acute Ischemic Stroke - The Clot Thickens
static version
printer friendly
pdf version
Arrhythmia Update 2000: Developments in Drugs Versus Devices
static version
printer friendly
pdf version
^ Top
C
Cardiac Marker Diagnostic Testing Markets
static version
printer friendly
pdf version
Cardiac Markers - Making their Mark on the Medicines Market
static version
printer friendly
pdf version
Cardiac Pacing and ICDs, 5th Edition
static version
printer friendly
pdf version
Cardiac Rhythm Management Devices World Markets
static version
printer friendly
pdf version
Cardiology - Acute Coronary Syndrome, Anticoagulants
static version
printer friendly
pdf version
Cardiology Drug Licensing Opportunities, 2002
static version
printer friendly
pdf version
Cardiology, Competitive Strategies, 2002
static version
printer friendly
pdf version
Cardiovascular and Circulatory System - Angina Drug Pipeline Report
static version
printer friendly
pdf version
Cardiovascular and Circulatory System - Arrhythmiasis Drug Pipeline Report
static version
printer friendly
pdf version
Cardiovascular and Circulatory System - Atherosclerosis or Coronary Artery Disease Drug Pipeline Report
static version
printer friendly
pdf version
Cardiovascular and Circulatory System - Congestive Heart Failure Drug Pipeline Report
static version
printer friendly
pdf version
Cardiovascular and Circulatory System - Edema Drug Pipeline Report
static version
printer friendly
pdf version
Cardiovascular and Circulatory System - Hypercholesterolemia Drug Pipeline Report
static version
printer friendly
pdf version
Cardiovascular and Circulatory System - Hypertension Drug Pipeline Report
static version
printer friendly
pdf version
Cardiovascular and Circulatory System - Intermittent Claudication Drug Pipeline Report
static version
printer friendly
pdf version
Cardiovascular and Circulatory System - Ischemia
static version
printer friendly
pdf version
Cardiovascular and Circulatory System - Ischemia Drug Pipeline Report
static version
printer friendly
pdf version
Cardiovascular and Circulatory System - Myocardial Infarction Drug Pipeline Report
static version
printer friendly
pdf version
Cardiovascular and Circulatory System - Peripheral Vascular Disease Drug Pipeline Report
static version
printer friendly
pdf version
Cardiovascular and Circulatory System - Stroke Drug Pipeline Report
static version
printer friendly
pdf version
Cardiovascular and Circulatory System - Thrombosis Drug Pipeline Report
static version
printer friendly
pdf version
Cardiovascular and Circulatory System Acute Coronary Syndromes
static version
printer friendly
pdf version
Cardiovascular and Circulatory System Angina
static version
printer friendly
pdf version
Cardiovascular and Circulatory System Arrhythmiasis
static version
printer friendly
pdf version
Cardiovascular and Circulatory System Atherosclerosis or Coronary Artery Disease
static version
printer friendly
pdf version
Cardiovascular and Circulatory System Congestive Heart Failure
static version
printer friendly
pdf version
Cardiovascular and Circulatory System Edema
static version
printer friendly
pdf version
Cardiovascular and Circulatory System Hypercholesterolemia
static version
printer friendly
pdf version
Cardiovascular and Circulatory System Hypertension
static version
printer friendly
pdf version
Cardiovascular and Circulatory System Intermittent Claudication
static version
printer friendly
pdf version
Cardiovascular and Circulatory System Myocardial Infarction
static version
printer friendly
pdf version
Cardiovascular and Circulatory System Peripheral Vascular Disease
static version
printer friendly
pdf version
Cardiovascular and Circulatory System Stroke
static version
printer friendly
pdf version
Cardiovascular and Circulatory System Thrombosis
static version
printer friendly
pdf version
Cardiovascular Disease Diagnostics - Global Strategic Business Report
static version
printer friendly
pdf version
Cardiovascular Disease: Current Research, Devices and Drugs
static version
printer friendly
pdf version
Cardiovascular Drug Delivery - Technologies, Markets and Companies
static version
printer friendly
pdf version
Cardiovascular Drug Discoveries 2008
static version
printer friendly
pdf version
Cardiovascular Drug Reviews
static version
printer friendly
pdf version
Cardiovascular Drug World Markets, 2003-2011
static version
printer friendly
pdf version
Cardiovascular Market Drugs and Devices Market: Successes and Cardiovascular Setbacks in the Third Quarter of 2005
static version
printer friendly
pdf version
Cardiovascular Therapy US Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles
static version
printer friendly
pdf version
Cardiovascular Therapy Worldwide Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles
static version
printer friendly
pdf version
Chinese Markets for Cardiovascular Drugs 2006
static version
printer friendly
pdf version
Chronic and Acute Heart Failure - Diversity and Disappointment
static version
printer friendly
pdf version
Chronic Obstructive Pulmonary Disease (COPD) 2008 Edition
static version
printer friendly
pdf version
Commercial Insight: Antidyslipidemics - Branded Statins Beware, Generics Are Amongst You
static version
printer friendly
pdf version
Commercial Insight: Cardiovascular Market Overview - Raft of Patent Expires Threaten Blockbusters
static version
printer friendly
pdf version
Competitor Analysis: Antihypertensives
static version
printer friendly
pdf version
Competitor Analysis: Antithrombotics
static version
printer friendly
pdf version
Competitor Analysis: Cholesterol Management
static version
printer friendly
pdf version
Competitor Analysis: Thrombolytic Agents
static version
printer friendly
pdf version
Congestive Heart Failure: Advances in Treatment and Their Potential Market
static version
printer friendly
pdf version
Congestive Heart Failure: Opinion Leader Forum Expert's Views and Perspective on Diagnosis,Treatment, Product Performance and Closing the Need Gap
static version
printer friendly
pdf version
^ Top
D
Diabetes, Metabolic Syndrome and Cardiovascular Disease Markets
static version
printer friendly
pdf version
Diabetic Cardiology
static version
printer friendly
pdf version
Disease and Therapy Review: Chronic Obstructive Pulmonary Disease
static version
printer friendly
pdf version
Disease and Therapy Review: Heart Failure
static version
printer friendly
pdf version
Disease and Therapy Review: Hypertension
static version
printer friendly
pdf version
Disease and Therapy Review: Myocardial Infaction
static version
printer friendly
pdf version
Disease and Therapy Review: Stroke
static version
printer friendly
pdf version
Drug Delivery Systems in Cardiovascular Therapeutics
static version
printer friendly
pdf version
Drugs of Tomorrow 2001: Hypertension - The Mounting Pressures Facing New Compounds
static version
printer friendly
pdf version
Drugs of Tomorrow 2002: Reperfusion Injury - The Next Breakthrough in Clinical Cardiology
static version
printer friendly
pdf version
Drugs, Devices and Procedures of Tomorrow: Acute Stroke - Chasing the need for speed
static version
printer friendly
pdf version
Dyslipidemia: Opportunities in Cardiovascular Risk Reduction
static version
printer friendly
pdf version
Dyslipidemia: The Expanding Market for Statins and other Lipid Management Products
static version
printer friendly
pdf version
^ Top
E
Emerging Technologies in Global Vascular Intervention: Peripheral Stenting
static version
printer friendly
pdf version
Emerging Technologies in Heart Valves - European Marketplace
static version
printer friendly
pdf version
Emerging Technologies in Replacement Heart Valves: US Marketplace
static version
printer friendly
pdf version
Essential Hypertension and Its Causes: Neural and Non-Neural Mechanisms
static version
printer friendly
pdf version
European Cardiovascular Drugs Markets
static version
printer friendly
pdf version
European Markets for Arrhythmia Management Products, 2000-2011
static version
printer friendly
pdf version
European Stroke Therapy Markets
static version
printer friendly
pdf version
^ Top
F
Functional Foods, Cardiovascular Disease and Diabetes
static version
printer friendly
pdf version
^ Top
H
High-Density Lipoproteins: From Basic Biology to Clinical Aspects
static version
printer friendly
pdf version
Hypertension Plus Heart Failure - Evaluation & Management Guidelines
static version
printer friendly
pdf version
^ Top
I
Innovations in Cardiovascular Disease Management: Latest Surgical Procedures, Drugs and Medical Devices
static version
printer friendly
pdf version
International (Non-US) Coronary Stent Dollar Volume by Region, 2000-2004
static version
printer friendly
pdf version
^ Top
K
Key Trends in European Patient Monitoring Systems Market
static version
printer friendly
pdf version
^ Top
M
Manual of Surgical Treatment of Atrial Fibrillation
static version
printer friendly
pdf version
Market Dynamics 2001: Anti-hypertensives - Aiirbs battle for supremacy
static version
printer friendly
pdf version
Market Dynamics 2001: Anticoagulants - The Advent of a New Generation of Agents
static version
printer friendly
pdf version
Market Dynamics 2001: Antiplatelets and Thrombolytics - Combination therapies key to market development
static version
printer friendly
pdf version
Medications to Treat High Blood Cholesterol
static version
printer friendly
pdf version
^ Top
N
Nuclear Cardiology Markets 2007
static version
printer friendly
pdf version
^ Top
O
Oxford Handbook of Cardiology, First Edition
static version
printer friendly
pdf version
^ Top
P
Partneringdesk Deals and alliances in cardiovascular diseases
static version
printer friendly
pdf version
Partneringreview 2006: Biopharma Deal Making By Therapy Area - Cardiovascular/Circulatory
static version
printer friendly
pdf version
Preventing Cardiovascular Events: Will HDL Therapeutics Change the Treatment Paradigm?
static version
printer friendly
pdf version
Pulmonary Hypertension: New Potential in a Limited Market
static version
printer friendly
pdf version
^ Top
R
Renin Inhibitors: A Novel Approach to Hypertension
static version
printer friendly
pdf version
Reverse Heart Disease Now: Stop Deadly Cardiovascular Plaque Before Its Too Late
static version
printer friendly
pdf version
Risk Stratification in the Diagnosis of Cardiovascular Disease
static version
printer friendly
pdf version
rTPAs State-of-the-Science and Strategic Opportunities
static version
printer friendly
pdf version
^ Top
S
Stakeholder Insight: Atherosclerosis - HDL, ApoA-I, Carotid MRI and 64-slice CT Offer Opportunities for Future Treatment
static version
printer friendly
pdf version
Stakeholder Opinions: Heart Failure - When Drugs Do Not Work
static version
printer friendly
pdf version
Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse Events With Drug-Eluting Stents Demand A New Safety Standard
static version
printer friendly
pdf version
Strastegic Perspectives 2001: Diabetic Hypertension - Towards Aggressive, Individual and Holistic Treatment Strategies
static version
printer friendly
pdf version
Strategic Perspectives 2001: Cardiovascular Gene Therapy - Injecting New Life Into Mature Markets
static version
printer friendly
pdf version
Strategic Perspectives 2001: CV Major Players
static version
printer friendly
pdf version
Strategic Perspectives: Marketed Antithrombotics - Plavix Adopts Lovenox's Developmental Defense Strategy
static version
printer friendly
pdf version
Strategic Perspectives: Microvascular Complications in Diabetes
static version
printer friendly
pdf version
Successful Management of Heart Failure Patients: Multidisciplinary Approach to Reducing Readmissions
static version
printer friendly
pdf version
^ Top
T
Target Product Profiles 2008: Physician Insights on Key Attributes - Chronic Obstructive Pulmonary Disease
static version
printer friendly
pdf version
Target Product Profiles 2008: Physician Insights on Key Attributes - Hypertension
static version
printer friendly
pdf version
The Asian Cardiovascular Market Outlook to 2010
static version
printer friendly
pdf version
The Cardiovascular Market Outlook to 2008
static version
printer friendly
pdf version
The Cardiovascular Market Outlook to 2009
static version
printer friendly
pdf version
The Cardiovascular Market Outlook to 2010
static version
printer friendly
pdf version
The Cardiovascular Market Outlook to 2011
static version
printer friendly
pdf version
The Cardiovascular Outlook to 2007
static version
printer friendly
pdf version
The Eastern European Cardiovascular Market Outlook to 2010
static version
printer friendly
pdf version
The Latin American Cardiovascular Market Outlook to 2010
static version
printer friendly
pdf version
The Nuts and Bolts of Cardiac Pacing, 2nd Edition
static version
printer friendly
pdf version
The Outlook for Cardiovascular Risk Factors: Epidemiology, market and pipeline analysis
static version
printer friendly
pdf version
Thought Leader Insight & Analysis: Non-Interventional Cardiology
static version
printer friendly
pdf version
Thrombolytics: State-of-the-Science and Strategic Opportunities
static version
printer friendly
pdf version
Thrombosis in Cancer: A New Challenge For Low Molecular Weight Heparins
static version
printer friendly
pdf version
Thrombosis: Growth opportunities for Antithrombotics and Thrombolytics
static version
printer friendly
pdf version
TPA in Stroke: Treatment Patterns and Potential
static version
printer friendly
pdf version
Treatment Algorithms 2001: Stroke - Time is Brain
static version
printer friendly
pdf version
Treatment Algorithms 2001: Venous Thromboembolism - Prophylaxis
static version
printer friendly
pdf version
Treatment Algorithms 2002: Heart failure - managing chronic and acute patients
static version
printer friendly
pdf version
Treatment Algorithms 2002: Venous Thromboembolism Acute Therapy
static version
printer friendly
pdf version
Treatment of Elevated Cholesterol
static version
printer friendly
pdf version
^ Top
U
U.S. Atrial Fibrillation Products Markets, 2005-2010
static version
printer friendly
pdf version
U.S. Coronary Stents Markets 2007
static version
printer friendly
pdf version
U.S. Pulmonary Arterial Hypertension Markets
static version
printer friendly
pdf version
Update: The Cardiovascular Outlook 2000
static version
printer friendly
pdf version
US Markets for Interventional Cardiology Accessory Devices
static version
printer friendly
pdf version
^ Top
V
Vascular Targeting Agents Current Status and Strategic Opportunities
static version
printer friendly
pdf version
Vascular Targeting Agents: Emerging Competitors
static version
printer friendly
pdf version
Vytorin: Wave Two - Impact of ENHANCE Trial
static version
printer friendly
pdf version
^ Top
W
Worldwide Heart Valve Market: Focus on Tissue Valves
static version
printer friendly
pdf version
Worldwide PTCA Dollar Volume by Region, 2000-2004
static version
printer friendly
pdf version
Worldwide PTCA Procedures by Region, 2000-2004
static version
printer friendly
pdf version
Worldwide PTCA Unit Sales by Region, 2000-2004
static version
printer friendly
pdf version
All rights reserved. © copyright 2006 Research and Markets
Terms and conditions
Privacy Policy